glucose tetrasaccharide has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul, S; Brettschneider, J; Dotan, N; Fire, E; Hill, HR; Husebye, D; Jaskowski, TD; Rose, JW; Seraj, H; Spector, L; Tumani, H; Yarden, J | 1 |
| Dotan, N; Glass-Marmor, L; Gortler, M; Karni, A; Miller, A; Schwarz, M; Spector, L; Weisshaus, O | 1 |
2 other study(ies) available for glucose tetrasaccharide and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
Topics: Adult; Aged; Cohort Studies; Female; Glucose; Humans; Immunoenzyme Techniques; Immunoglobulin M; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Nervous System Diseases; Oligosaccharides; Statistics, Nonparametric | 2009 |
Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.
Topics: Adult; Autoantibodies; Biomarkers; False Positive Reactions; Female; Fluorescent Antibody Technique; Humans; Immunoglobulin M; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Oligosaccharides; Polysaccharides; Predictive Value of Tests | 2006 |